ESAB insider trades: option exercise and same‑day sale recorded

Rhea-AI Filing Summary

ESAB Corp (ESAB) — Form 4 insider activity: A director reported routine transactions. On 07/18/2025, 6.848 shares of common stock were acquired via dividend reinvestment at $127.56 per share. On 11/11/2025, the director exercised 2,783 stock options at $33.02 and sold 2,783 shares at $114.50. Following these transactions, directly owned common shares were 8,741.91.

Insider Trade Summary

Net Seller: 2,783 shares ($318,654)

Net Sell 4 txns

Insider Vinnakota Rajiv

Role Director

Sold 2,783 shs ($319K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	2,783	$0.00	--
Exercise	Common stock, par value $0.001	2,783	$33.02	$92K
Sale	Common stock, par value $0.001	2,783	$114.50	$319K
L	Common stock, par value $0.001	6.848	$127.56	$873.53

Holdings After Transaction: Stock Option (right to buy) — 0 shares (Direct); Common stock, par value $0.001 — 11,524.91 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vinnakota Rajiv

(Last) (First) (Middle)

909 ROSE AVE, 8TH FLOOR

(Street)

NORTH BETHESDA MD 20852

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ESAB Corp [ ESAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	07/18/2025		L		6.848(1)	A	$127.56	8,741.91	D
Common stock, par value $0.001	11/11/2025		M		2,783	A	$33.02	11,524.91	D
Common stock, par value $0.001	11/11/2025		S		2,783	D	$114.5	8,741.91	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$33.02	11/11/2025		M			2,783	04/05/2022	05/13/2026	Common stock, par value $0.001	2,783	$0	0	D

Explanation of Responses:

1. Represents 6.848 shares of common stock acquired through the reinvestment of dividends.

Remarks:

	/s/ Curtis E. Jewell, Attorney-in-Fact	11/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did ESAB (ESAB) report?

A director acquired 6.848 shares via dividend reinvestment on 07/18/2025, exercised 2,783 options at $33.02 on 11/11/2025, and sold 2,783 shares at $114.50 the same day.

How many ESAB shares does the director own after the transactions?

Directly owned common shares were 8,741.91 after the reported activity.

What was the option exercise price and amount for ESAB?

The director exercised 2,783 stock options at an exercise price of $33.02 on 11/11/2025.

At what price were ESAB shares sold by the director?

2,783 shares were sold at $114.50 on 11/11/2025.

What was the source of the 6.848 ESAB shares acquired?

They were acquired through the reinvestment of dividends on 07/18/2025.

What happened to the exercised ESAB options after the transaction?

The stock option for 2,783 shares was fully exercised, leaving 0 derivative securities beneficially owned following the transaction.